Verdict No. 3050 · Search date 2026-09-08 · Methodology v1.0
Steamed ginger extract GGE03, 0.48 g/day,
does it really help with Reduction of pain in mild knee osteoarthritis?
30-Second Summary
C
Evidence Grade C · 46 · Safety caution
Only VAS pain with GGE03 is judged; function, structural change, and EV.EXT77 are separate.
Caution. Mixed oral-ginger trials had more withdrawals for adverse events than placebo. Twelve weeks cannot establish long-term safety or medicine interactions.
What the
research showsGrade C with 46 points. A 100-person double-blind trial reported better VAS and K-WOMAC pain after GGE03 0.48 g/day for 12 weeks, but the public abstract does not provide the exact between-group effect, 95% CI, or prespecified principal endpoint. EV.EXT77, a ginger-galangal combination, was excluded.
research showsGrade C with 46 points. A 100-person double-blind trial reported better VAS and K-WOMAC pain after GGE03 0.48 g/day for 12 weeks, but the public abstract does not provide the exact between-group effect, 95% CI, or prespecified principal endpoint. EV.EXT77, a ginger-galangal combination, was excluded.
What the
ads claimThe trial does not show that generic ginger powder regenerates cartilage or replaces NSAIDs.
ads claimThe trial does not show that generic ginger powder regenerates cartilage or replaces NSAIDs.
Useful facts when choosing a product
- This verdict applies only to the exact formulation, route, dose, duration, population, endpoint, and comparator shown above.
- Ginger food, powder, standardized extract, essential oil, topical products, and combination products are not interchangeable.
- Caution. Mixed oral-ginger trials had more withdrawals for adverse events than placebo. Twelve weeks cannot establish long-term safety or medicine interactions.
Chamgap Semantic Classification Code
Permanent code issued
S.steamed-ginger-extract.oral.knee-osteoarthritis-pain.reduce.placeboSupplements and nutraceuticals > GGE03 steamed ginger extract > Oral > Knee-osteoarthritis pain > Reduction claim > Placebo
Bound to GGE03 0.48 g/day for 12 weeks; the ginger-galangal EV.EXT77 combination was excluded. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | S · Supplement or nutraceutical |
|---|---|
| Canonical ingredient or intervention | GGE03 steamed ginger extract |
| Source or part used | Rhizome of Zingiber officinale |
| Formulation or processing | Steamed extract GGE03; extraction solvent and gingerol/shogaol assay unverified in the public abstract |
| Route | Oral |
| Dose | 0.48 g/day GGE03 in 1.6 g/day total product |
| Duration | 12 weeks of treatment and follow-up |
| Population | 100 adults with mild knee osteoarthritis |
| Effect or condition | Knee-pain reduction |
| Primary endpoint | 12-week VAS pain; K-WOMAC pain supportive |
| Comparator | Matching placebo |
| Duplicate-detection key | gge03-steamed-ginger-extract|oral-product|oral|adult-mild-knee-osteoarthritis|vas-pain-reduction|12-weeks |
Gap Measurement · Verdict 3050 · C 46
What the research actually shows
The GGE03 trial was compared with 2015 and 2020 syntheses, and the galangal component of EV.EXT77 was kept separate.
Why this is classified as C (46)
A formulation-specific RCT signal remains, but unverified magnitude, hierarchy, independent replication, and company role yield C with 46 points.
Counterpoint. A five-trial mixed oral-ginger meta-analysis found only a small pain effect (SMD -0.30) and more adverse-event withdrawals.
Rejudgment record. Independent Codex cross-check — One formulation, one route, one population, one claim, one principal endpoint and comparator
Scoring profile behind this grade
| Endpoint | P | Patient-reported treatment goal - the symptom is the goal |
| Replication | R1 | Single confirmatory trial |
| Independence | I0 | Evidence comes only from manufacturer studies |
| Effect size | EX | The clinical size of the effect could not be judged |
| Precision | CX | No pooled confidence interval could be confirmed |
The scoring table and the verdict agree (C).
Cross-check — AI research and Codex final gate
AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Effectiveness and safety of steamed ginger extract on mild osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial | The cited design, allocation, masking, endpoint hierarchy, and analysis limitations were independently checked. | 1 | Funding, product support, employee authorship, and declared conflicts were assessed separately. | The principal endpoint contract is preserved; secondary outcomes remain separate. | Verified estimates are preserved; missing confidence intervals or event counts were not invented. | Evidence weight reflects directness, formulation match, endpoint hierarchy, and reporting limitations. |
| Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials | The cited design, allocation, masking, endpoint hierarchy, and analysis limitations were independently checked. | 593 | Funding, product support, employee authorship, and declared conflicts were assessed separately. | The principal endpoint contract is preserved; secondary outcomes remain separate. | Verified estimates are preserved; missing confidence intervals or event counts were not invented. | Evidence weight reflects directness, formulation match, endpoint hierarchy, and reporting limitations. |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-09-08).
Kim K et al. Food Funct. 2024;15:9065-9074. PMID: 39212491. DOI: 10.1039/D4FO01651J.
checkedBartels EM et al. Osteoarthritis Cartilage. 2015;23:13-21. PMID: 25300574. DOI: 10.1016/j.joca.2014.09.024. PROSPERO CRD42011001777.
checkedResearch and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-08 · Corrections: none
Final verification and publication gate: Codex · Verification cutoff: 2026-09-08 · Corrections: none
Cite this verdict
[Chamgap] GGE03 Ginger Extract for Knee Pain—A 100-Person Trial Was Positive, but Magnitude and Independent Replication Are Incomplete — Evidence Grade C·46. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/oral-steamed-ginger-extract-mild-knee-osteoarthritis-pain/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.